A ARGX

Argen X SE

BIOTECHNOLOGY · HEALTHCARE

argenx NV, based in Breda, the Netherlands, is a forward-thinking clinical-stage biotechnology company focused on delivering transformative antibody-based treatments for severe autoimmune diseases, hematological disorders, and various cancers. Leveraging its proprietary technology platform, argenx i...

$892.87

-0.55% ($4.98)

Volume 461,292

52W High $1,072.75

52W Low $661.85

Market Cap $56.27B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 22, 2026 Beat

Actual: $7.80 vs. Consensus: $7.44

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q3 2026 Oct 22, 2026

1-Day: -0.23%

5-Day: +0.77%

Q2 2026 Jul 23, 2026

1-Day: -0.69%

5-Day: -5.66%

Q1 2026 May 7, 2026

1-Day: -0.65%

5-Day: +3.24%

Q4 2025 Feb 26, 2026

1-Day: -0.60%

5-Day: -2.96%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$1.72B	+52.7%	90.4%	28.2%	$506.0M
Q2'26	$2.82B	+197.0%	90.1%	30.1%	$838.8M
Q1'26	$1.30B	+64.2%	90.7%	30.4%	$366.0M
Q4'25	$3.21B	+138.1%	89.4%	26.5%	$1.05B
Q3'25	$1.13B	+96.6%	90.3%	30.8%	$344.0M
Q2'25	$948.0M	+65.4%	88.3%	21.5%	$245.4M
Q1'25	$790.7M	+97.2%	89.8%	17.9%	$169.5M
Q4'24	$1.35B	+235.7%	50.6%	8.7%	$865.6M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 22, 2026	$7.44	-$27.83	$7.80	+4.84%	Beat
Q2 2026	Jul 23, 2026	$6.13	$6.86	$7.32	+19.41%	Beat
Q1 2026	May 7, 2026	$4.92	$4.82	$5.52	+12.20%	Beat
Q4 2025	Feb 26, 2026	$6.24	$6.05	$8.02	+28.53%	Beat
Q3 2025	Oct 30, 2025	$4.16	$5.11	$5.18	+24.52%	Beat
Q2 2025	Jul 31, 2025	$3.02	$3.00	$3.74	+23.84%	Beat
Q2 2025	Jul 15, 2025	-$0.99	-$0.99	$3.26	--	Beat
Q1 2025	May 8, 2025	$2.31	$2.36	$2.58	+11.69%	Beat
Q1 2025	May 7, 2025	$2.05	$2.36	$2.27	+10.64%	Missed
Q4 2024	Mar 31, 2025	$1.70	$1.95	$0.71	-58.04%	Missed
Q4 2024	Feb 27, 2025	$1.70	$1.95	$0.71	-58.04%	Missed
Q3 2024	Oct 31, 2024	$0.06	$0.03	$1.39	--	Beat